Monthly information related to total number of voting rights and shares composing the share capital – March 29, 2024

In this article:
Phaxiam Therapeutics S.A.Phaxiam Therapeutics S.A.
Phaxiam Therapeutics S.A.


Article 223-16 of general regulation of French Autorité des Marchés Financiers


Listing market: Euronext Paris (Market segment C - ISIN Code: FR001400K4B1- Symbol: PHXM)
Website : www.phaxiam.com

Date

Total of shares composing the share capital

Total of brut (1) voting rights



Total of net (2) voting rights

December 31, 2023

6 075 105

6 226 982

6 226 733

January 31, 2024

6 075 105

6 227 002

6 226 753

February 29, 2024

6 075 105

6 226 951

6 226 702

March 29, 2024

6 075 105

6 226 938

6 226 689

(1)   Gross voting rights number (or ? theoretical ? voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2)   Without treasury shares.

Attachment


Advertisement